These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3317343)

  • 21. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
    Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interruption of perinatal transmission of HBV by Chinese recombinant hepatitis B vaccine].
    Yang C; Chen D; Li S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Dec; 15(6):343-5. PubMed ID: 7874702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparing immunogenicity and efficacy of two hepatitis B vaccines in newborn infants of hepatitis B surface antigen (+)/hepatitis B e antigen (+) carrier mothers].
    Liu Y; Liu X; Kuang J
    Zhonghua Fu Chan Ke Za Zhi; 1999 Aug; 34(8):470-2. PubMed ID: 11360596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term immunogenicity and efficacy of recombinant yeast derived hepatitis B vaccine for interruption of mother-infant transmission of hepatitis B virus.
    Zhu QR; Gu XH; Duan SC; Xu HF
    Chin Med J (Engl); 1994 Dec; 107(12):915-8. PubMed ID: 7882730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine.
    André FE
    Am J Med; 1989 Sep; 87(3A):14S-20S. PubMed ID: 2528292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children].
    Liang Z; Li C; Jing Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):165-7. PubMed ID: 10322792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The long-term efficacy of a recombinant hepatitis B vaccine in newborns].
    Tejedor Torres JC; Reyes Pecharromán S; Pérez Rivilla A; Sayalero Martín M; Aybar Garciá L; Sánchez de León L; Puyol Buil P
    An Esp Pediatr; 1993 Sep; 39(3):243-7. PubMed ID: 8250440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of vaccinated infants born to HBsAg-positive mothers with different hepatitis B vaccines and doses.
    Kuru U; Turan O; Kuru N; Sağlam Z; Alver A
    Turk J Pediatr; 1995; 37(2):93-102. PubMed ID: 7597774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immediate immunological effect of China-made recombinant hepatitis B vaccine expressed by transgenic Chinese hamster ovary cell line].
    Liu H; Ma J; Meng Z; Zhang Y; Han C; Zhang Y; Zhao H; Liu Y; Xing Z; Chen J; Jia Z; Xia G; Cao H; Liu C; Li Z
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):43-6. PubMed ID: 11953126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B vaccination and the rate of seroconversion in high risk contacts.
    Sengupta B; Sarkar A; De M; Lahiri P; Bhattacharya DK
    J Indian Med Assoc; 1993 Nov; 91(11):281-2, 285. PubMed ID: 8138648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult hepatitis B vaccination using a novel triple antigen recombinant vaccine.
    Young MD; Schneider DL; Zuckerman AJ; Du W; Dickson B; Maddrey WC;
    Hepatology; 2001 Aug; 34(2):372-6. PubMed ID: 11481622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection].
    Xia GL; Gong J; Wang JJ; Meng ZD; Jia ZY; Cao HL; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):362-5. PubMed ID: 12820927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
    Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to hepatitis B vaccination in high risk population.
    Prakash C; Bhatia R; Kumari S; Verghese T; Datta KK
    J Commun Dis; 2000 Mar; 32(1):17-21. PubMed ID: 11129560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of a recombinant, yeast-derived, anti-hepatitis-B vaccine after alternative dosage and schedule vaccination in Pakistani children.
    Akram DS; Maqbool S; Khan DS; Jafri R; Randhawa S; Valenzuela-Silva C; Lopez-Saura P
    Vaccine; 2005 Dec; 23(50):5792-7. PubMed ID: 16303217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.